Specifically, Dittrich et al. [20] examined the effects of combined treatment with ACE inhibitors (enalapril) and β-blockers (metoprolol) in a German cohort encompassing 38 children with DMD (mean age: 11 years, range: 9–13). Here, ACE is linked to Duchenne muscular dystrophy.